| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |